177 related articles for article (PubMed ID: 9399721)
1. Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure.
Grossman E; Messerli FH
Am J Cardiol; 1997 Dec; 80(11):1453-8. PubMed ID: 9399721
[TBL] [Abstract][Full Text] [Related]
2. Effect of calcium antagonists on sympathetic activity.
Grossman E; Messerli FH
Eur Heart J; 1998 Jun; 19 Suppl F():F27-31. PubMed ID: 9651732
[TBL] [Abstract][Full Text] [Related]
3. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension.
Fogari R; Zoppi A; Corradi L; Preti P; Malalamani GD; Mugellini A
J Hypertens; 2000 Dec; 18(12):1871-5. PubMed ID: 11132613
[TBL] [Abstract][Full Text] [Related]
4. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study.
Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Fluckiger L; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; van Roon AM; Smit AJ
Am J Hypertens; 2001 Nov; 14(11 Pt 1):1083-9. PubMed ID: 11724204
[TBL] [Abstract][Full Text] [Related]
5. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.
Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
J Hypertens; 2007 Jan; 25(1):169-75. PubMed ID: 17143189
[TBL] [Abstract][Full Text] [Related]
6. Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension.
Kawano Y; Makino Y; Okuda N; Takishita S; Omae T
Blood Press Monit; 2000 Jun; 5(3):181-5. PubMed ID: 10915232
[TBL] [Abstract][Full Text] [Related]
7. Heart rate in hypertensive patients treated with ACE inhibitors and long-acting dihydropyridine calcium antagonists.
Pierdomenico SD; Bucci A; Lapenna D; Cuccurullo F; Mezzetti A
J Cardiovasc Pharmacol; 2002 Aug; 40(2):288-95. PubMed ID: 12131558
[TBL] [Abstract][Full Text] [Related]
8. Time course for blood pressure lowering of dihydropyridine calcium channel blockers.
Ghamami N; Chiang SH; Dormuth C; Wright JM
Cochrane Database Syst Rev; 2014 Aug; (8):CD010052. PubMed ID: 25173808
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension.
Binggeli C; Corti R; Sudano I; Luscher TF; Noll G
Hypertension; 2002 Apr; 39(4):892-6. PubMed ID: 11967245
[TBL] [Abstract][Full Text] [Related]
10. Relation between blood pressure and plasma catecholamine concentration after administration of calcium antagonists to rats.
Imai K; Higashidate S; Prados PR; Santa T; Adachi-Akahane S; Nagao T
Biol Pharm Bull; 1994 Jul; 17(7):907-10. PubMed ID: 8000374
[TBL] [Abstract][Full Text] [Related]
11. Role of calcium antagonists in the treatment of essential hypertension.
Klein W; Brandt D; Vrecko K; Härringer M
Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension.
Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; Smit AJ
Br J Clin Pharmacol; 2001 Dec; 52(6):687-92. PubMed ID: 11736880
[TBL] [Abstract][Full Text] [Related]
13. Use of calcium channel blockers in hypertension.
Conlin PR; Williams GH
Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
[TBL] [Abstract][Full Text] [Related]
14. Safety aspects of treatment with lacidipine--a slow-onset, long-acting calcium antagonist.
Lindholm LH; Tcherdakoff P; Zanchetti A
Blood Press; 1996 Jul; 5(4):241-9. PubMed ID: 8809376
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel antagonists: friend or foe in postinfarction patients?
Gibson RS; Boden WE
Am J Hypertens; 1996 Dec; 9(12 Pt 2):172S-176S. PubMed ID: 8968429
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind comparison of 10 and 20 mg lercanidipine in patients with stable effort angina: effects on myocardial ischemia and heart rate variability.
Acanfora D; Trojano L; Gheorghiade M; Picone C; Papa A; Furgi G; Giuliano F; Maestri R; Rengo F
Am J Ther; 2002; 9(5):444-53. PubMed ID: 12237738
[TBL] [Abstract][Full Text] [Related]
17. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension.
Kailasam MT; Parmer RJ; Cervenka JH; Wu RA; Ziegler MG; Kennedy BP; Adegbile IA; O'Connor DT
Hypertension; 1995 Jul; 26(1):143-9. PubMed ID: 7607717
[TBL] [Abstract][Full Text] [Related]
18. Effect of amlodipine on norepinephrine kinetics and baroreflex function in patients with congestive heart failure.
Goldsmith SR
Am Heart J; 1997 Jul; 134(1):13-9. PubMed ID: 9266778
[TBL] [Abstract][Full Text] [Related]
19. Dihydropyridine calcium channel antagonists in the management of hypertension.
Epstein BJ; Vogel K; Palmer BF
Drugs; 2007; 67(9):1309-27. PubMed ID: 17547473
[TBL] [Abstract][Full Text] [Related]
20. Lacidipine: a review of its use in the management of hypertension.
McCormack PL; Wagstaff AJ
Drugs; 2003; 63(21):2327-56. PubMed ID: 14524737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
